Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Total Current Liabilities: 2015-2019

Historic Total Current Liabilities for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to $20.3 million.

  • Outlook Therapeutics' Total Current Liabilities fell 20.52% to $18.5 million in Q2 2020 from the same period last year, while for Jun 2020 it was $18.5 million, marking a year-over-year decrease of 20.52%. This contributed to the annual value of $20.3 million for FY2019, which is 36.68% down from last year.
  • According to the latest figures from FY2019, Outlook Therapeutics' Total Current Liabilities is $20.3 million, which was down 36.68% from $32.0 million recorded in FY2018.
  • In the past 5 years, Outlook Therapeutics' Total Current Liabilities registered a high of $37.0 million during FY2015, and its lowest value of $20.3 million during FY2019.
  • Moreover, its 3-year median value for Total Current Liabilities was $28.7 million (2017), whereas its average is $27.0 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first plummeted by 44.83% in 2016, then spiked by 40.62% in 2017.
  • Yearly analysis of 5 years shows Outlook Therapeutics' Total Current Liabilities stood at $37.0 million in 2015, then slumped by 44.83% to $20.4 million in 2016, then skyrocketed by 40.62% to $28.7 million in 2017, then grew by 11.50% to $32.0 million in 2018, then plummeted by 36.68% to $20.3 million in 2019.